Anterix initiates strategic review, appoints new chairman; Q3 cash $28.8M, $3B pipeline

Anterix Inc.

Tom Kuhn appointed Executive Chairman after Morgan O'Brien retirement; strategic review started after inbound interest.
Cash $28.8M, no debt; $147M contracted proceeds outstanding; $1M from Ameren, $34M from Oncor.
Projected ~20% reduction in operating expense run rate for FY2026; $3B pipeline with 60+ potential customers.
18 utilities above DI threshold (~$1B potential); signed contracts ~$390M; $500M in Phase 3.
Share repurchase program has $229.6M remaining; Q3 buyback of $4.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.